Memometal Technologies S.A., a global extremity orthopaedic manufacturer headquartered in France, announced today that it has completed the acquisition of all the assets of Advanced Bio-Surfaces (ABS) Corporation’s OrthoGlide® Ankle Technology.
“OrthoGlide Ankle Technology represents a new option for foot and ankle surgeons,” said Alan Taylor, General Manager of Memometal Technologies’ U.S. subsidiary, MMI-USA of Memphis. “This technology and intellectual property will produce an implant similar to the unicompartmental knee; it can be used as a less invasive treatment for the ankle patient w...
The Orthopedics Industry 